Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...
Impact of concomitant medication use on treatment outcomes in patients with RCC treated with immune checkpoint inhibitors. First-in-human phase 0 safety, imaging, pharmacokinetics, and dosimetry study ...
PN and RFA offer similar survival for cT1a RCC tumors ≤2 cm, but PN is superior for larger tumors. RFA may be considered for elderly patients with comorbidities, especially for tumors ≤2 cm. PN ...
In a study, partial nephrectomy was associated with a 66% lower risk for stage 4 or higher CKD versus radical nephrectomy. Kidney cancer patients have a lower risk of developing stage 4 or higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback